La vendita allo scoperto per DarioHealth dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di DarioHealth. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

DarioHealth (NASDAQ:DRIO) Azioni, Report sulle vendite allo scoperto

DarioHealth

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

DRIO

NRDY

RRGB

Gli insider acquistano penny stock sotto i $5: scopri le 3 azioni da monitorare per potenziali opportunità di investimento.

3 penny stock sotto i $5 che gli insider stanno comprando

DarioHealth Corp

Macro Economic Events

WIIM

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are lower following Israel's Thursday strikes on Iran, which have driven oil prices up and caused macro uncertainty.

APLD

Applied Digital shares are trading lower after an amended Schedule 13G filing showed that CoreWeave sold its stake in Applied Digital.

Politics

Global

General

iShares MSCI Israel Capped Investable Market Index Fund

Reuters In Phone Interview With President Trump Cites Him Saying Israel's Ultimate Objective Is To Ensure Iran Does Not Possess A Nuclear Weapon

Reuters In Phone Interview With President Trump Cites Him Saying "We Knew Everything" About Israel's Strike On Iran, "I Tried To Save Iran Humiliation And Death"; Says He Is Not Concerned About A Regional War Breaking Out As A Result Of Israel's Strike On Iran

Reuters In Phone Interview With President Trump Cites Him Saying That It's Not Too Late For Iran To Make A Deal; U.S. Still Has Meeting Planned With Iran On Sunday But Says He Is Not Sure If It Will Now Take Place; Iran Suffered A Devastating Hit And It Is Unclear If Iran Still Has A Nuclear Program

Pearson PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSO#NYSE">PSO</a>) announced Friday that it will acquire eDynamic Learning, a leading provider of Career and Technical Education (CTE) curriculum solutions, in a move aimed at strengthening its position in <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/n45924400/pearson-to-acquire-career-and-technical-education-leader-edynamic-learning" rel="noreferrer noopener">the Early Careers education market</a>.
The financial terms of the transaction were not disclosed.
eDynamic Learning serves over 885,000 students across more than 9,000 K-12 institutions, offering 325 digital courses across 40 career pathways.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45928757/amd-serious-ai-contender-with-sights-on-over-500-billion-tam-billions-in-revenue-analyst" rel="noreferrer noopener">AMD &#8216;Serious AI Contender&#8217; With Sights On Over $500 Billion TAM, Billions In Revenue: Analyst</a>
Its programs also extend to post-secondary learners and adult professionals, focusing on career preparation through virtual simulations, workforce training, and teaching services.
The acquisition supports Pearson&#8217;s strategy to expand its career-readiness offerings and meet rising demand for skills-based learning programs.
The deal will be funded through Pearson&#8217;s existing cash reserves and available liquidity, with completion expected in the second half of 2025.
Pearson CEO Omar Abbosh said the acquisition reflects a growing urgency among employers for job-ready talent in an era increasingly shaped by artificial intelligence.
&#8220;Employers tell us they have an urgent need for career-ready workers,&#8221; Abbosh said, adding that the partnership will help address this skills gap.
As demand for workforce-aligned education accelerates, Pearson&#8217;s acquisition positions it to deliver more targeted, scalable solutions for early career learners entering a rapidly evolving job market.
Pearson held cash and cash equivalents of <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n44034472/pearson-2024-preliminary-results-unaudited" rel="noreferrer noopener">543 million pounds</a> as of December 31, 2024.
Related ETFs: Global X Education ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDUT#NASDAQ">EDUT</a>), Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
Price Action: PSO shares are trading lower by 1.72% to $14.57 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45920453/trumps-student-loan-policies-could-inflict-massive-economic-harm-for-americans-warns-expert-instead-of-helping-the-5-million-borrowers" target="_blank" rel="noreferrer noopener">Trump&#8217;s Student Loan Policies Could Inflict &#8216;Massive Economic Harm,&#8217; For Americans, Warns Expert: &#8216;Instead Of Helping The 5 million Borrowers&#8230;&#8217;</a></li>
</ul>
Photo by PeopleImages.com Yuri A via Shutterstock

Tech

EDUT

Pearson Targets Growing Skills Gap With Acquisition Of eDynamic Learning

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) with a Buy and maintains $77 price target.

Price Target

Reiteration

Analyst Ratings

CAPR

HC Wainwright & Co. Reiterates Buy on Capricor Therapeutics, Maintains $77 Price Target

Asset Sales

CRWV

CoreWeave Discloses Complete Exit From Applied Digital In Amended Schedule 13G Filing, Reports 0% Ownership As Of June 10, 2025

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXS#NASDAQ">ATXS</a>) with a Buy and maintains $16 price target.

ATXS

HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $16 Price Target

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) has outperformed the market over the past 20 years by 11.48% on an annualized basis producing an average annual return of 19.79%. Currently, Gartner has a market capitalization of $31.83 billion. 
Buying $100 In IT: If an investor had bought $100 of IT stock 20 years ago, it would be worth $3,670.35 today based on a price of $413.59 for IT at the time of writing.
<h3>Gartner's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749828625_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Gartner 20 Years Ago Would Be Worth This Much Today

AFCG

Advanced Flower Capital shares are trading lower after Zuanic & Associates downgraded the stock from Overweight to Neutral.

ASTS

AST SpaceMobile shares are trading higher after the company announced a settlement term sheet that facilitates long-term access to up to 45 MHz of premium lower mid-band spectrum in North America.

Wolfe Research analyst Keith Stanley upgrades Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) from Underperform to Peer Perform.

Upgrades

Wolfe Research Upgrades Williams Companies to Peer Perform

SNES

SenesTech shares are trading higher after the company announced that Baltimore concluded its initial pilot program and is now transitioning to a broader deployment of Evolve.

BSAAU

Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Wolfe Research analyst Nigel Coe downgrades GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) from Outperform to Peer Perform.

Downgrades

Wolfe Research Downgrades GE Vernova to Peer Perform

RBC Capital analyst Arun Viswanathan initiates coverage on Air Products (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) with a Outperform rating and announces Price Target of $355.

Initiation

RBC Capital Initiates Coverage On Air Products with Outperform Rating, Announces Price Target of $355

TLSA

Tiziana Life Sciences shares are trading higher after the company announced it commenced the dosing at the ongoing Phase 2 clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis.

Reuters Cites Israel's UN Envoy Saying, We Don't Know How Long Operation In Iran Will Take; Will Continue To Act Until We Will Know That We Have Eliminated The Threats From Iran

Insight Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>) has outperformed the market over the past 15 years by 3.92% on an annualized basis producing an average annual return of 15.79%. Currently, Insight Enterprises has a market capitalization of $4.21 billion. 
Buying $100 In NSIT: If an investor had bought $100 of NSIT stock 15 years ago, it would be worth $882.61 today based on a price of $132.48 for NSIT at the time of writing.
<h3>Insight Enterprises's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749827713_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NSIT

$100 Invested In Insight Enterprises 15 Years Ago Would Be Worth This Much Today

Small Cap

Press Releases

/C O R R E C T I O N -- DarioHealth Corp./

Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth

Contracts

Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion

DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers

DarioHealth Announces CFO Transition

DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives

DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025

Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations

Earnings

DarioHealth Reports First Quarter 2025 Financial and Operating Results

Market Alert: DarioHealth Receives $3 Price Target and Buy Rating: Everything You Need to Know

Comments

DarioHealth

Vendite allo scoperto

DarioHealth (NASDAQ:DRIO) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO